Following clinical trials, considerable investment and a great deal of anticipation the long-action version of diabetes drug Byetta now faces an approval decision by the Food and Drug Administration. The drug is being sold by Amylin Pharmaceuticals alongside Eli Lilly and Co.
Byetta LAR is injected just once each week, and is thought to be a key drug in the future of Amylin. The drug is also thought to be crucial for Eli Lilly. The treatment will open up a different lifestyle for people with diabetes who use the drug .
Experts anticipate an approval for the drug, following an approval by the FDA of Victoza. Both drugs are similar to GLP-1, a human hormone that boosts the production of insulin to regulate blood glucose levels. However, some experts predict a delay in the approval process.
Diabetes injection Byetta LAR faces Food and Drug Administration decision
Wed, 10 Mar 2010
Recommended links
Diabetes forumDiabetes myLifestyle
Diabetes donate
Diabetes signs and symptoms
What is HbA1c
Diabetes and Byetta
Diabetes pensions and annuities
The Diet Plate for People with Diabetes
Diabetes ID alert wristband
GlaxoSmithKline defends diabetes drug Avandia
Patient concern over diabetes drug Avandia
Food and Drug Administration say diabetes patients should not stop taking Avandia
Popular Cholesterol drugs increase diabetes risk
Smell of fish may put patients off diabetes drug
24 hour Diabetes drug Victoza approved for National Health Service use
Diabetes drug could cut body mass index
Weight loss drug alli could reduce dangerous diabetes fat
Type 2 diabetes drug gets Food and Drug Administration approval
Lexicon diabetes drug hits mid-stage trial
Diabetes drug clinical trials underway
Death risk increased 60 per cent by diabetes drug
Roche diabetes drug hits targets
New type 1 diabetes drug
Diabetes drug warning has doctors on alert
Label change for type 2 diabetes drug
Diabetes prevention using diet, not drugs
Diabetes drug better for weight loss
Diabetes drug may have pancreatitis risk
Denial over diabetes drug link
Heart risk not alleviated by diabetes drugs
Obesity increases diabetes drug bill
Med diet could delay diabetes drugs
Diabetes drug prescriptions must stop, study says
Stop prescribing diabetes drug, scientists say
Get forum updates, competition previews & diabetes community news.
